MyJournals Home  

RSS Feeds[Correspondence] Teriparatide vs risedronate for osteoporosis - Authors` reply (Lancet)

 
 

13 may 2018 00:00:19

 
[Correspondence] Teriparatide vs risedronate for osteoporosis - Authors` reply (Lancet)
 




Yair Liel stated that the VERO clinical trial1 results were of relatively minor clinical significance because of the nature of the active comparator used (risedronate) and because bone turnover markers were not measured, suggesting that the inferior anti-fracture efficacy in the risedronate group was not evaluated properly. He suggested that a clinically relevant comparison could be made between teriparatide and zoledronate, or between teriparatide and denosumab, given their superior effects on bone mineral density observed when compared with oral bisphosphonates.


Del.icio.us Digg Facebook Google StumbleUpon Twitter
 
123 viewsCategory: General
 
[Correspondence] Teriparatide vs risedronate for osteoporosis (Lancet)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

General

Use these buttons to bookmark us:
Del.icio.us Digg Facebook Google StumbleUpon Twitter


Valid HTML 4.01 Transitional
Copyright © 2008 - 2018 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Travel Photos Nachrichten Indigonet Finances Leer Mandarijn